Thyroid Cancer Coverage from Every Angle

Recent News

8-Week Relative Dose Intensity: Predictive of Outcomes With Lenvatinib in Thyroid Cancer?
AACR 2021: Can a Plant-Derived Alkaloid Reprogram the Inflammatory Environment in Thyroid Cancer?
Strategies for Managing Low-Risk Papillary Thyroid Microcarcinoma: Consensus Statements From JAES
Spectroscopically Speaking: Metabolic Features of Malignant and Benign Thyroid Lesions
Sternal Metastasis and Thyroid Carcinoma: A Rare Combination
Rare Onset of Ocular Choroidal and Pituitary Metastases From Differentiated Thyroid Cancer
Updated ATA Guidelines for Managing Anaplastic Thyroid Cancer
Prevalence of COVID-19 in Patients With Thyroid Cancer: View From Italian Referral Center
Lenvatinib in Radioiodine-Refractory Thyroid Cancer: Potential Prognostic Markers
Lenvatinib as Potential Salvage Treatment in Advanced Medullary Thyroid Cancer
Treating Isthmic Papillary Thyroid Cancer With Ultrasound-Guided Microwave Ablation
FDA Grants Breakthrough Therapy Designation to Cabozantinib in Differentiated Thyroid Cancer
Chinese Study Focuses on Role of Reproductive Factors in the Risk for Thyroid Cancer
Case Study Features Rare Comorbidity of Papillary Thyroid Carcinoma
Can Digoxin Improve RAI Sensitivity in Resistant Nonmedullary Thyroid Cancer?
Diagnosing Autonomous Thyroid Nodules With Ultrasonography in Children and Adolescents
Are Physicians Confident in Ultrasonography’s Ability to Detect Thyroid Cancer Recurrence?
Rare Case of Concurrent Idiopathic Hypoparathyroidism and Papillary Thyroid Carcinoma
PSMA PET: A Potential Theranostic Agent in Thyroid Cancer?
Australian Community Juries Address Overtreatment of Low-Risk Papillary Thyroid Cancer
Effect of In Utero Exposure to Thyroid Cancer on Risk of Disease in Offspring
Potential Cardiovascular Risks of Thyroid Cancer Therapy and Hyperthyroidism
Surgical Guidelines for Low-Risk Differentiated Thyroid Cancer by Tumor Size
Novel Approach to Restoring Sodium-Iodide Symporter Expression in Anaplastic Thyroid Cancer
IL1RN Expression: Potential Diagnostic and Prognostic Biomarker for Papillary Thyroid Carcinoma?
Diagnosis of Indeterminate Thyroid Nodules: Comparison of Current Molecular Testing Techniques
Surgical Management of Cervical Spine Metastases From Differentiated Thyroid Cancers
Case Report: Neoadjuvant Selpercatinib in RET‐Mutated Medullary Thyroid Cancer
Lymph Node Yield Threshold in Lateral Neck Dissection for Papillary Thyroid Carcinoma
ESMO Asia 2020: Anlotinib in Radioiodine-Refractory Differentiated Thyroid Carcinoma
Pralsetinib Granted FDA Approval in Treatment of RET-Altered Thyroid Cancers
SITC 2020: Checkpoint Inhibitor Pair Tested in Thyroid Malignancies
Are Serum Thyroglobulin Levels a Reliable Marker of Recurrence in Thyroid Cancer?
Simultaneous Primary Hyperparathyroidism and Thyroid Carcinomas: Rare Case Study
ASTRO 2020: High-Dose Iodine-131 Ablation for High-Risk Thyroid Cancer
ASTRO 2020: Locoregional Failure Patterns With IMRT for Anaplastic Thyroid Cancer
ASTRO 2020: Does a Reduced Radiation Field Decrease Toxicity in Advanced Thyroid Cancer?
Lenvatinib in Advanced Anaplastic Thyroid Cancer: Real-World Setting
Differentiated Thyroid Cancer Korean Study Focuses on Unusual Metastases

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.